Targeting CAND1 promotes caspase-8/RIP1-dependent apoptosis in liver cancer cells

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cullin-associated NEDD8-dissociated 1 (CAND1) regulates Cullin-RING ubiquitin ligases (CRLs), crucial in cancer.
• The role of CAND1 in hepatocellular carcinoma (HCC) is currently unknown.

Purpose of the Study:

• To investigate the role and prognostic significance of CAND1 in HCC.
• To explore the therapeutic potential of targeting CAND1 in liver cancer.

Main Methods:

• Analysis of CAND1 expression in HCC tissues versus adjacent tissues.
• Correlation of CAND1 expression with patient survival data.
• In vitro functional studies involving CAND1 knockdown in liver cancer cells.
• Investigation of apoptosis pathways, including caspase-8 and Receptor Interacting Protein 1 (RIP1).

Main Results:

• CAND1 was significantly overexpressed in HCC tissues (71.7%) compared to normal liver tissues (16.7%).
• High CAND1 expression correlated with poorer overall survival and identified CAND1 as an independent prognostic risk factor in HCC patients.
• CAND1 knockdown suppressed HCC cell proliferation by inducing caspase-8-dependent mitochondrial apoptosis.
• A mutual activation loop between caspase-8 and RIP1 amplified apoptosis, which was blocked by the RIP1 inhibitor Necrostatin-1.

Conclusions:

• High CAND1 expression serves as a predictive biomarker for poor prognosis in HCC.
• Targeting CAND1 through silencing induces apoptosis in HCC cells via the caspase-8/RIP1 pathway.
• CAND1 represents a potential novel therapeutic target for hepatocellular carcinoma.